•
Jan 31

HealthEquity Q4 2025 Earnings Report

HealthEquity reported strong fourth-quarter results with significant year-over-year revenue growth and solid profitability.

Key Takeaways

HealthEquity delivered a 19% revenue increase in Q4 FY25 compared to the previous year, alongside stable net income and improved non-GAAP EPS. The company saw growth across service, custodial, and interchange revenue streams, and highlighted continued expansion in total accounts and HSA assets.

Revenue rose 19% year-over-year to $311.8 million.

Net income remained stable at $26.4 million, matching Q4 FY24 results.

Non-GAAP EPS increased from $0.63 to $0.69.

Strong growth in HSA accounts and assets, with total HSA assets reaching $32.1 billion.

Total Revenue
$312M
Previous year: $262M
+18.8%
EPS
$0.69
Previous year: $0.63
+9.5%
Total HSAs
9.89M
Previous year: 8.69M
+13.8%
HSAs with investments
753K
Previous year: 610K
+23.4%
Total CDBs
7.14M
Previous year: 7.01M
+2.0%

HealthEquity

HealthEquity

HealthEquity Revenue by Segment

Forward Guidance

Management expects continued strong growth for fiscal year 2026 with higher revenue, net income, and adjusted EBITDA projections.

Positive Outlook

  • Revenue guidance between $1.28B and $1.305B for FY26.
  • Net income projected between $164M and $179M.
  • Non-GAAP net income forecasted between $318M and $333M.
  • Expected Adjusted EBITDA between $525M and $545M.
  • Continued focus on strategic initiatives and member growth.

Challenges Ahead

  • Potential impacts from macroeconomic factors.
  • Possible regulatory changes affecting tax-advantaged benefits.
  • Competitive pressures in healthcare benefits market.
  • Dependence on third-party vendors and partners.
  • Risk of cybersecurity threats impacting operations.